Cite
HARVARD Citation
Tsien, C. et al. (2023). NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. Journal of clinical oncology. 41 (6), pp. 1285-1295. [Online].